BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 14611646)

  • 1. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.
    Fischer P; Lehmann U; Sobota RM; Schmitz J; Niemand C; Linnemann S; Haan S; Behrmann I; Yoshimura A; Johnston JA; Müller-Newen G; Heinrich PC; Schaper F
    Biochem J; 2004 Mar; 378(Pt 2):449-60. PubMed ID: 14611646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
    Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
    J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130.
    Schmitz J; Weissenbach M; Haan S; Heinrich PC; Schaper F
    J Biol Chem; 2000 Apr; 275(17):12848-56. PubMed ID: 10777583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130.
    Lehmann U; Schmitz J; Weissenbach M; Sobota RM; Hortner M; Friederichs K; Behrmann I; Tsiaris W; Sasaki A; Schneider-Mergener J; Yoshimura A; Neel BG; Heinrich PC; Schaper F
    J Biol Chem; 2003 Jan; 278(1):661-71. PubMed ID: 12403768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
    Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
    FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of gp130 signalling mediated through tyrosine-757 is not dependent on the recruitment of SHP2.
    Fairlie WD; De Souza D; Nicola NA; Baca M
    Biochem J; 2003 Jun; 372(Pt 2):495-502. PubMed ID: 12593670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tyrosine 974 within the LIF-R-chain of the gp130/LIF-R heteromeric receptor complex mediates negative regulation of LIF signalling.
    Clahsen T; Lehmann U; Stross C; Hermanns HM; Volkmer-Engert R; Schneider-Mergener J; Heinrich PC; Schaper F
    Cell Signal; 2005 May; 17(5):559-69. PubMed ID: 15683731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.
    Kim H; Baumann H
    Mol Cell Biol; 1999 Aug; 19(8):5326-38. PubMed ID: 10409724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A family of cytokine-inducible inhibitors of signalling.
    Starr R; Willson TA; Viney EM; Murray LJ; Rayner JR; Jenkins BJ; Gonda TJ; Alexander WS; Metcalf D; Nicola NA; Hilton DJ
    Nature; 1997 Jun; 387(6636):917-21. PubMed ID: 9202125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of STAT3 by IL-6 and IL-10 in primary human macrophages is differentially modulated by suppressor of cytokine signaling 3.
    Niemand C; Nimmesgern A; Haan S; Fischer P; Schaper F; Rossaint R; Heinrich PC; Müller-Newen G
    J Immunol; 2003 Mar; 170(6):3263-72. PubMed ID: 12626585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation.
    Tone E; Kunisada K; Kumanogoh A; Negoro S; Funamoto M; Osugi T; Kishimoto T; Yamauchi-Takihara K
    Cytokine; 2000 Oct; 12(10):1512-8. PubMed ID: 11023666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction of IL-6, leukemia-inhibitory factor, and oncostatin M: structural receptor requirements for signal attenuation.
    Anhuf D; Weissenbach M; Schmitz J; Sobota R; Hermanns HM; Radtke S; Linnemann S; Behrmann I; Heinrich PC; Schaper F
    J Immunol; 2000 Sep; 165(5):2535-43. PubMed ID: 10946280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and function of a new STAT-induced STAT inhibitor.
    Naka T; Narazaki M; Hirata M; Matsumoto T; Minamoto S; Aono A; Nishimoto N; Kajita T; Taga T; Yoshizaki K; Akira S; Kishimoto T
    Nature; 1997 Jun; 387(6636):924-9. PubMed ID: 9202127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling.
    Tanuma N; Shima H; Nakamura K; Kikuchi K
    Blood; 2001 Nov; 98(10):3030-4. PubMed ID: 11698287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory roles for SHP-1 and SOCS-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor.
    Bousquet C; Susini C; Melmed S
    J Clin Invest; 1999 Nov; 104(9):1277-85. PubMed ID: 10545526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the interleukin-6 receptor subunit glycoprotein 130 complex and its signaling by LMO4 interaction.
    Novotny-Diermayr V; Lin B; Gu L; Cao X
    J Biol Chem; 2005 Apr; 280(13):12747-57. PubMed ID: 15677447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different protein turnover of interleukin-6-type cytokine signalling components.
    Siewert E; Müller-Esterl W; Starr R; Heinrich PC; Schaper F
    Eur J Biochem; 1999 Oct; 265(1):251-7. PubMed ID: 10491180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
    Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.